<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34707521</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-0640</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in psychiatry</Title><ISOAbbreviation>Front Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Clinical Heterogeneity in ME/CFS. A Way to Understand Long-COVID19 Fatigue.</ArticleTitle><Pagination><StartPage>735784</StartPage><MedlinePgn>735784</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">735784</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpsyt.2021.735784</ELocationID><Abstract><AbstractText>The aim of present paper is to identify clinical phenotypes in a cohort of patients affected of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Ninety-one patients and 22 healthy controls were studied with the following questionnaires, in addition to medical history: visual analogical scale for fatigue and pain, DePaul questionnaire (post-exertional malaise, immune, neuroendocrine), Pittsburgh sleep quality index, COMPASS-31 (dysautonomia), Montreal cognitive assessment, Toulouse-Pi&#xe9;ron test (attention), Hospital Anxiety and Depression test and Karnofsky scale. Co-morbidities and drugs-intake were also recorded. A hierarchical clustering with clinical results was performed. Final study group was made up of 84 patients, mean age 44.41 &#xb1; 9.37 years (66 female/18 male) and 22 controls, mean age 45 &#xb1; 13.15 years (14 female/8 male). Patients meet diagnostic criteria of Fukuda-1994 and Carruthers-2011. Clustering analysis identify five phenotypes. Two groups without fibromyalgia were differentiated by various levels of anxiety and depression (13 and 20 patients). The other three groups present fibromyalgia plus a patient without it, but with high scores in pain scale, they were segregated by prevalence of dysautonomia (17), neuroendocrine (15), and immunological affectation (19). Regarding gender, women showed higher scores than men in cognition, pain level and depressive syndrome. Mathematical tools are a suitable approach to objectify some elusive features in order to understand the syndrome. Clustering unveils phenotypes combining fibromyalgia with varying degrees of dysautonomia, neuroendocrine or immune features and absence of fibromyalgia with high or low levels of anxiety-depression. There is no a specific phenotype for women or men.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Murga, Aranburu, Gargiulo, G&#xf3;mez Esteban and Lafuente.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Murga</LastName><ForeName>I&#xf1;igo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>LaNCE-Neuropharm Group, Department of Neuroscience, University of the Basque Country (UPV-EHU), Leioa, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aranburu</LastName><ForeName>Larraitz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Mathematics, University of the Basque Country (UPV-EHU), Leioa, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gargiulo</LastName><ForeName>Pascual A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Lab Experimental Psychology, Consejo Nacional de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Department of Pathology, Universidad Nacional de Cuyo (UNC), Mendoza, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez Esteban</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>LaNCE-Neuropharm Group, Department of Neuroscience, University of the Basque Country (UPV-EHU), Leioa, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurodegenerative Disease Group, Biocruces Research Institute, Barakaldo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lafuente</LastName><ForeName>Jos&#xe9;-Vicente</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>LaNCE-Neuropharm Group, Department of Neuroscience, University of the Basque Country (UPV-EHU), Leioa, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurodegenerative Disease Group, Biocruces Research Institute, Barakaldo, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Psychiatry</MedlineTA><NlmUniqueID>101545006</NlmUniqueID><ISSNLinking>1664-0640</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chronic Fatigue Syndrome</Keyword><Keyword MajorTopicYN="N">Myalgic Encephalomyelitis</Keyword><Keyword MajorTopicYN="N">dysautonomia</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">post-viral fatigue</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34707521</ArticleId><ArticleId IdType="pmc">PMC8542754</ArticleId><ArticleId IdType="doi">10.3389/fpsyt.2021.735784</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Acheson ED. A new clinical entity? Lancet. (1956) 267:789&#x2013;90. 10.1016/S0140-6736(56)91252-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(56)91252-1</ArticleId><ArticleId IdType="pubmed">13320887</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. (2020) 324:603&#x2013;05. 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Murga I, Lafuente JV. De la neurastenia a la enfermedad post-esfuerzo: evoluci&#xf3;n de los criterios diagn&#xf3;sticos del S&#xed;ndrome de Fatiga Cr&#xf3;nica/Encefalomielitis Mi&#xe1;lgica. Atenci&#xf3;n Primaria. (2019) 51:579&#x2013;85. 10.1016/j.aprim.2019.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aprim.2019.04.004</ArticleId><ArticleId IdType="pmc">PMC6945124</ArticleId><ArticleId IdType="pubmed">31182238</ArticleId></ArticleIdList></Reference><Reference><Citation>Parish JG. Early outbreaks of &#x2018;epidemic neuromyasthenia'. Postgrad. Med. J. (1978) 54:711&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2425322</ArticleId><ArticleId IdType="pubmed">370810</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsay MA. Myalgic Encephalomyelitis and Postviral Fatigue States: The Saga of Royal Free Disease. 2nd ed. Londres: Gower Publishing Co. (1988).</Citation></Reference><Reference><Citation>Carruthers BM, van de Sande MI, de Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. . Myalgic encephalomyelitis: international consensus criteria. J Intern Med. (2011) 270:327&#x2013;38. 10.1111/j.1365-2796.2011.02428.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Zinn ML, Zinn MA. Myalgic encephalomyelitis: symptoms and biomarkers. Curr Neuropharmacol. (2015) 13:701&#x2013;34. 10.2174/1570159X13666150928105725</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X13666150928105725</ArticleId><ArticleId IdType="pmc">PMC4761639</ArticleId><ArticleId IdType="pubmed">26411464</ArticleId></ArticleIdList></Reference><Reference><Citation>Maksoud R, du Preez S, Eaton-Fitch N, Thapaliya K, Barnden L, Cabanas H, et al. . A systematic review of neurological impairments in myalgic encephalomyelitis/chronic fatigue syndrome using neuroimaging techniques. PLoS ONE. (2020) 15:e0232475. 10.1371/journal.pone.0232475</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0232475</ArticleId><ArticleId IdType="pmc">PMC7192498</ArticleId><ArticleId IdType="pubmed">32353033</ArticleId></ArticleIdList></Reference><Reference><Citation>Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dub&#xe9; M, et al. . Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. (2020) 12:14. 10.3390/v12010014</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12010014</ArticleId><ArticleId IdType="pmc">PMC7020001</ArticleId><ArticleId IdType="pubmed">31861926</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. . Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China. JAMA Neurol. (2020) 77:683&#x2013;90. 10.1001/jamaneurol.2020.1127</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S, Nora-Krukle Z, Henning N, Eliassen E, Shikova E, Harrer T, et al. . Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. (2018) 16:268. 10.1186/s12967-018-1644-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The Chronic Fatigue Syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. (1994) 121:953&#x2013;9. 10.7326/0003-4819-121-12-199412150-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType="pubmed">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton EW, Alegr&#xed;a M, Bateman L, Chu L, Cleeland C, Ronald WD, et al. . Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Redefining and illness Washington: National Academies Press; (2015).</Citation></Reference><Reference><Citation>Gower J. A general coefficient of similarity and some of its properties. Biometrics. (1971) 27:857&#x2013;71. 10.2307/2528823</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2528823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward JH. Hierarchical Grouping to optimize an objective function. J Am Stat Assoc. (1963) 58:236&#x2013;44. 10.1080/01621459.1963.10500845</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621459.1963.10500845</ArticleId></ArticleIdList></Reference><Reference><Citation>Afari N, Buchwald D. Chronic fatigue syndrome: a review. Am J Psychiatry. (2003) 160:221&#x2013;36. 10.1176/appi.ajp.160.2.221</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.160.2.221</ArticleId><ArticleId IdType="pubmed">12562565</ArticleId></ArticleIdList></Reference><Reference><Citation>Prins JB, van der Meer JW, Bleijenberg G. Chronic fatigue syndrome. Lancet. (2006) 367:346&#x2013;55. 10.1016/S0140-6736(06)68073-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(06)68073-2</ArticleId><ArticleId IdType="pubmed">16443043</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. . Autonomic dysfunction in &#x2018;long COVID': rationale, physiology and management strategies. Clin Med (Lond). (2021) 21:e63&#x2013;7. 10.7861/clinmed.2020-0896</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawley E. Pediatric chronic fatigue syndrome: current perspectives. Pediatr Health Med Therap. (2018) 9:27&#x2013;33. 10.2147/PHMT.S126253</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/PHMT.S126253</ArticleId><ArticleId IdType="pmc">PMC5919160</ArticleId><ArticleId IdType="pubmed">29722371</ArticleId></ArticleIdList></Reference><Reference><Citation>Miles OW, Maren S. Role of the bed nucleus of the stria terminalis in PTSD: insights from preclinical models. Front Behav Neurosci. (2019) 13:68. 10.3389/fnbeh.2019.00068</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnbeh.2019.00068</ArticleId><ArticleId IdType="pmc">PMC6461014</ArticleId><ArticleId IdType="pubmed">31024271</ArticleId></ArticleIdList></Reference><Reference><Citation>Clauss J. Extending the neurocircuitry of behavioural inhibition: a role for the bed nucleus of the stria terminalis in risk for anxiety disorders. Gen Psychiatr. (2019) 32:e100137. 10.1136/gpsych-2019-100137</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gpsych-2019-100137</ArticleId><ArticleId IdType="pmc">PMC6937153</ArticleId><ArticleId IdType="pubmed">31922088</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebow MA, Chen A. Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders. Mol Psychiatry. (2016) 21:450&#x2013;63. 10.1038/mp.2016.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2016.1</ArticleId><ArticleId IdType="pmc">PMC4804181</ArticleId><ArticleId IdType="pubmed">26878891</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakatomi Y, Kuratsune H, Watanabe Y. Neuroinflammation in the brain of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Brain Nerve. (2018) 70:19&#x2013;25. 10.11477/mf.1416200945</Citation><ArticleIdList><ArticleId IdType="doi">10.11477/mf.1416200945</ArticleId><ArticleId IdType="pubmed">29348371</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L, Valencia IJ, Garvert DW, Montoya JG. Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome. Front Pediatr. (2019) 7:12. 10.3389/fped.2019.00012</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2019.00012</ArticleId><ArticleId IdType="pmc">PMC6370741</ArticleId><ArticleId IdType="pubmed">30805319</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Sorenson M, Porter N, Belkairous N. An etiological model for myalgic encephalomyelitis/chronic fatigue syndrome. Neurosci Med. (2011) 2:14&#x2013;27. 10.4236/nm.2011.21003</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/nm.2011.21003</ArticleId><ArticleId IdType="pmc">PMC3166239</ArticleId><ArticleId IdType="pubmed">21892413</ArticleId></ArticleIdList></Reference><Reference><Citation>Arruti M, Avellaneda A, Barbado FJ, De la Cruz J, D&#xed;az-Delgado R, Gutierrez E. Documento de Consenso S&#xed;ndrome Fatiga Cr&#xf3;nica. Madrid: Editorial M&#xe9;dica A.W.W.E. S.A; (2008).</Citation></Reference><Reference><Citation>Stoothoff J, Gleason K, Mc Manimen S, Thorpe T, Jason LA. Subtyping patients with myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS) by course of illness. J Biosens Biomark Diagn. (2017) 2:1&#x2013;16. 10.15226/2575-6303/2/1/00113</Citation><ArticleIdList><ArticleId IdType="doi">10.15226/2575-6303/2/1/00113</ArticleId><ArticleId IdType="pmc">PMC5710812</ArticleId><ArticleId IdType="pubmed">29204592</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotler J, Holtzman C, Dudun C, Jason LA. A brief questionnaire to assess Post- Exertional Malaise. Diagnostics. (2018) 8:66. 10.3390/diagnostics8030066</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics8030066</ArticleId><ArticleId IdType="pmc">PMC6165517</ArticleId><ArticleId IdType="pubmed">30208578</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels J, Brigden A, Kacorova A. Anxiety and depression in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): examining the incidence of health anxiety in CFS/ME. Psychol Psychother. (2017) 90:502&#x2013;9. 10.1111/papt.12118</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/papt.12118</ArticleId><ArticleId IdType="pubmed">28244209</ArticleId></ArticleIdList></Reference><Reference><Citation>Kielholz P. Die Larvierte Depression. Bern-Stuttgart-Vienne-Paris: Editorial Hans Huber; (1973).</Citation></Reference><Reference><Citation>L&#xf3;pez-Ibor Ali&#xf1;o JJ. Los Equivalentes Depresivos. 2nd ed. Madrid: Editorial Paz Montalvo; (1976).</Citation></Reference><Reference><Citation>Van Cauwenbergh D, Nijs J, Kos D, Van Weijnen L, Struyf F, Meeus M. Malfunctioning of the autonomic nervous system in patients with Chronic Fatigue Syndrome: a systematic literature review. Eur J Clin Investig. (2014) 44:516&#x2013;26. 10.1111/eci.12256</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.12256</ArticleId><ArticleId IdType="pubmed">24601948</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark JE, Ng WF, Rushton S, Watson S, Newton JL. Network structure underpinning (dys) homeostasis in chronic fatigue syndrome; preliminary findings. PLoS ONE. (2019) 14:e0213724. 10.1371/journal.pone.0213724</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0213724</ArticleId><ArticleId IdType="pmc">PMC6433252</ArticleId><ArticleId IdType="pubmed">30908516</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson LJ, Durham J, MacLachlan LL, Newton JL. Autonomic function in Chronic Fatigue Syndrome with and without painful temporomandibular disorder. Fatigue: Biomed. Health Behav. (2015) 3:205&#x2013;19.</Citation></Reference><Reference><Citation>Lewis I, Pairman J, Spickett G, Newton JL. Clinical characteristics of a novel subgroup of chronic fatigue syndrome patients with postural orthostatic tachycardia syndrome. J Intern Med. (2013) 273:501&#x2013;10. 10.1111/joim.12022</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12022</ArticleId><ArticleId IdType="pubmed">23206180</ArticleId></ArticleIdList></Reference><Reference><Citation>Cockshell SJ, Mathias JL. Cognitive functioning in chronic fatigue syndrome: a meta-analysis. Psychol Med. (2010) 40:1253&#x2013;67. 10.1017/S0033291709992054</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291709992054</ArticleId><ArticleId IdType="pubmed">20047703</ArticleId></ArticleIdList></Reference><Reference><Citation>Cvejic E, Birch RC, Vollmer-Conna U. Cognitive dysfunction in chronic fatigue syndrome: a review of recent evidence. Curr Rheumatol Rep. (2016) 18:24. 10.1007/s11926-016-0577-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-016-0577-9</ArticleId><ArticleId IdType="pubmed">27032787</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotts ZM. The role of sleep in Chronic Fatigue Syndrome (doctoral thesis). Newcastle: Northumbria University; (2014). p 71.</Citation></Reference><Reference><Citation>Theoharides TC, Asadi S, Weng Z, Zhang B. Serotonin-selective reuptake inhibitors and nonsteroidal anti-inflammatory drugs - important considerations of adverse interactions especially for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome. J Clin Psychopharmacol. (2011) 31:403&#x2013;5. 10.1097/JCP.0b013e318225848c</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JCP.0b013e318225848c</ArticleId><ArticleId IdType="pubmed">21694612</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux RK, Naviaux JC, Li K, Bright AT, Alaynick WA, Wang L, et al. . Metabolic features of chronic fatigue syndrome. PNAS. (2016) 113:E5472&#x2013;80. 10.1073/pnas.1607571113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607571113</ArticleId><ArticleId IdType="pmc">PMC5027464</ArticleId><ArticleId IdType="pubmed">27573827</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Benton MC, Valentine L, Johnson A, Torres-Harding S. The economic impact of ME/CFS: individual and societal costs. Dynamic Med. (2008) 7:6. 10.1186/1476-5918-7-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-5918-7-6</ArticleId><ArticleId IdType="pmc">PMC2324078</ArticleId><ArticleId IdType="pubmed">18397528</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Skendrovic B, Furst J, Brown A, Weng A, Bronikowski C. Data mining: comparing the empiric CFS to the Canadian ME/CFS case definition. J Clin Psychol. (2012) 68:41&#x2013;9. 10.1002/jclp.20827</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jclp.20827</ArticleId><ArticleId IdType="pmc">PMC3228898</ArticleId><ArticleId IdType="pubmed">21823124</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. (2021) 12:698169. 10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-a systemic review and comparison of clinical presentation and symptomatology. Medicina. (2021) 57:418. 10.3390/medicina57050418</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips S, Williams MA. Confronting our next national health disaster - long-haul covid. N Engl J Med. (2021) 385:577&#x2013;9. 10.1056/NEJMp2109285</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2109285</ArticleId><ArticleId IdType="pubmed">34192429</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>